Previous studies have observed that PHGDH inhibition induced autophagy in carcinoma cells but have attributed that effect to an mTOR-independent mechanism because of the lack of response to rapamycin treatment (Mita and Tolcher, 2007; Sharif et al., 2018). Here, PHGDH is linked to carcinoma.